Headline Trial Results The SLIMMER Phase 3 study enrolled 664 adults with overweight or obesity
And so these medications are quieting that noise, from the perspective of patients that have told me this
By contrast, peptides such as PYY and apelin were discontinued primarily due to formulation limitations or tolerability at supraphysiologic dosespharmacologic rather than biological failuresand therefore meet criteria for re-evaluation
Only a few studies have been done of Provigils effects on healthy, non-sleep-deprived volunteers, but those studies suggest that Provigil does provide an edge, at least for some kinds of challenges
SBKJ, MF, EJ, and SSS analyzed the fitness outcomes
In both treatment groups, higher weight loss at 3 months of treatment predicted super responder status (diet p=0.0098, exenatide p=0.0080)